Order Article Reprints

Yamazaki H, Suzuki G, Aibe N, Shimizu D, Kimoto T, Masui K, Yoshida K, Nakamura S, Hashimoto Y, Okabe H. Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer. Cancers. 2022; 14(1):195. https://doi.org/10.3390/cancers14010195

Yamazaki, Hideya, Gen Suzuki, Norihiro Aibe, Daisuke Shimizu, Takuya Kimoto, Koji Masui, Ken Yoshida, Satoaki Nakamura, Yasutoshi Hashimoto, and Haruumi Okabe. 2022. "Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer" Cancers 14, no. 1: 195. https://doi.org/10.3390/cancers14010195

Yamazaki, H., Suzuki, G., Aibe, N., Shimizu, D., Kimoto, T., Masui, K., Yoshida, K., Nakamura, S., Hashimoto, Y., & Okabe, H. (2022). Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer. Cancers, 14(1), 195. https://doi.org/10.3390/cancers14010195